LEADER 01712nam  2200397   450 
001 9910633969503321
005 20230326171550.0
010   $a1-83969-967-1
035   $a(CKB)5700000000338666
035   $a(NjHacI)995700000000338666
035   $a(EXLCZ)995700000000338666
100   $a20230326d2022      uy             0
101 0 $aeng
135   $aur|||||||||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 00$aNew knowledge about pulmonary thromboembolism /$fedited by Jelena Stojs?ic
210  1$aLondon :$cIntechOpen,$d[2022]
210  4$dİ2022
215   $a1 online resource (86 pages)
311   $a1-83969-966-3 
327   $a1. Introductory Chapter: Pulmonary Embolism. 2. Diagnosis of Pulmonary Embolism. 3. Pulmonary Embolism in COVID-19 Patients: Facts and Figures. 4. Anticoagulants in the Management of Pulmonary Embolism. 5. Thrombolytic Therapy in Pulmonary Thromboembolism.
330   $aThromboembolism is the most common cause of death in autopsied patients. Recently, this disorder has become a topic of interest due to it being a frequent complication of COVID-19 infection. This book discusses pulmonary thromboembolism in COVID-19 and non-COVID-19 patients, such as those with malignancies such as paraneoplastic symptoms or heart and lung diseases.
606   $aPulmonary embolism
606   $aThromboembolism
615  0$aPulmonary embolism.
615  0$aThromboembolism.
676   $a616.249
702   $aStojs?ic$b Jelena
801  0$bNjHacI
801  1$bNjHacl
906   $aBOOK
912   $a9910633969503321
996   $aNew knowledge about pulmonary thromboembolism$93086751
997   $aUNINA